Open Label, Single Arm, Phase II Study Using R-COMP in Elderly Patients With Aggressive NHL.

NCT00244127 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Aggressive Non-Hodgkin's Lymphoma in the Elderly.

Interventions

DRUG: Cyclophosphamide, oncovin, myocet, prednisone & rituximab (R-COMP)

Sponsor

Zeneus Pharma